The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of biological chemistry, 279.2004, 5, S. 3563-3572
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2021
- Urheber
-
Gewinner, Christina
Hart, Gerald W.
Zachara, Natasha
Cole, Robert
Beisenherz-Huss, Christian
Groner, Bernd
- DOI
-
10.1074/jbc.M306449200
- URN
-
urn:nbn:de:hebis:30:3-761859
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gewinner, Christina
- Hart, Gerald W.
- Zachara, Natasha
- Cole, Robert
- Beisenherz-Huss, Christian
- Groner, Bernd
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2021
Ähnliche Objekte (12)
NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the α-helical region of the STAT5 transactivation domain
Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1
Molecular mechanism of inhibition of the CREB-coactivator TORC by the mitogen-activated kinase DLK in pancreatic beta-cells
CReB
CReB?
O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies
Flexible promoter architecture requirements for coactivator recruitment
Mass spectrometric sequencing of O-glycosylated peptides
Synthesis of N‐Glycosylated Soluble Fas Ligand
Exposing the molecular heterogeneity of glycosylated biotherapeutics
Development of differentially glycosylated IgG antibodies
Liver and muscle hemojuvelin are differently glycosylated
NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the α-helical region of the STAT5 transactivation domain
Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1
Molecular mechanism of inhibition of the CREB-coactivator TORC by the mitogen-activated kinase DLK in pancreatic beta-cells
CReB
CReB?
O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies
Flexible promoter architecture requirements for coactivator recruitment
Mass spectrometric sequencing of O-glycosylated peptides
Synthesis of N‐Glycosylated Soluble Fas Ligand
Exposing the molecular heterogeneity of glycosylated biotherapeutics
Development of differentially glycosylated IgG antibodies
Liver and muscle hemojuvelin are differently glycosylated
NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the α-helical region of the STAT5 transactivation domain
Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1
Molecular mechanism of inhibition of the CREB-coactivator TORC by the mitogen-activated kinase DLK in pancreatic beta-cells
CReB
CReB?
O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies
Flexible promoter architecture requirements for coactivator recruitment
Mass spectrometric sequencing of O-glycosylated peptides
Synthesis of N‐Glycosylated Soluble Fas Ligand
Exposing the molecular heterogeneity of glycosylated biotherapeutics
Development of differentially glycosylated IgG antibodies